UNSPSC 85641763: Supplement of left lower leg subcutaneous tissue and fascia with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement of left lower leg subcutaneous tissue and fascia with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JUP0KZ

UNSPSC 85641763 Supplement of left lower leg subcutaneous tissue and fascia with nonautologous tissue substitute, open approach is a Commodity code that shows no relevant recent state and local procurement activity. The recent opportunities tagged under this code span independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, youth detention healthcare services, pharmacy benefit management, and temporary health professional staffing — none of which align with the orthopedic surgical procedure the code nominally describes. The mismatch suggests that either the code has been applied inconsistently in the state and local procurement systems or the code sees minimal direct procurement activity at the state and local level.

State and local buyers appear to pursue healthcare services, staffing, and benefit management through broader service-family codes rather than procedure-specific commodity codes. Issuers in the recent record include a municipal retirement office (City of Phoenix), a city employee benefits program (City of Long Beach), a state transportation agency (Washington State Department of Transportation), a county juvenile justice department (Harris County), a county health benefits consortium (Collier County), and a regional health system (County of Santa Clara). Recent solicitations close in October 2026 and target providers of occupational medicine, specialty centers of excellence, and ancillary clinical staffing rather than orthopedic implant or surgical procedure suppliers. No procurement opportunity in the source material involves the prosthetic or tissue-substitute products this commodity code describes.